Tag: IRB IEC

Interpreters in Study Visits: Training, Documentation and Role Boundaries Interpreters in Study Visits: Training, Documentation and Role Boundaries In the context of decentralized clinical trials, the inclusion of interpreters during study visits is critical to ensure effective communication between study personnel and participants. This article aims to provide comprehensive guidance on the training, documentation, and…

Read More “Interpreters in Study Visits: Training, Documentation and Role Boundaries” »

Handling Rare Languages and Low-Literacy Populations in Study Regions Effective communication is essential in the context of clinical trials, particularly when these trials aim to include diverse populations. In precision medicine clinical trials, the potential benefits for populations with rare languages or low literacy can be substantial, but they also present unique challenges. In this…

Read More “Handling Rare Languages and Low-Literacy Populations in Study Regions” »

Documenting Translation Processes for IRB/IEC and Regulatory Review The increasing globalization of clinical trials necessitates the effective documentation of translation processes for the review and approval by Institutional Review Boards (IRB) or Independent Ethics Committees (IEC) and regulatory authorities. This step-by-step tutorial provides clinical operations, regulatory affairs, and medical affairs professionals in the US, UK,…

Read More “Documenting Translation Processes for IRB/IEC and Regulatory Review” »

Language Access Policies to Support Equity in Participant Enrollment Language Access Policies to Support Equity in Participant Enrollment In the realm of clinical trials, achieving comprehensive participant enrollment is not only a goal but a necessity to ensure diverse and representative data. However, language barriers can profoundly affect participation rates, particularly among non-native speakers. This…

Read More “Language Access Policies to Support Equity in Participant Enrollment” »

Quality Control Checks for Critical Translated Study Documents Quality Control Checks for Critical Translated Study Documents In the context of clinical trials, accurate and effective communication is essential to ensure compliance with regulatory requirements and maintain patient safety. Due to the increasing globalization of clinical research, the demand for translated study documents has risen significantly….

Read More “Quality Control Checks for Critical Translated Study Documents” »

Budgeting for Translation and Interpretation in Study Financial Plans Budgeting for Translation and Interpretation in Study Financial Plans The complexity of conducting oncology clinical research necessitates a well-structured financial plan, particularly concerning language access and translation services. This article aims to provide a detailed step-by-step guide on how to integrate budgeting for translation and interpretation…

Read More “Budgeting for Translation and Interpretation in Study Financial Plans” »

Aligning Global Messaging Across Languages While Respecting Local Nuance Clinical trials operate within a global framework, requiring an intricate balance between standardized messaging and localized nuances, particularly in relation to language access and translation. For professionals in clinical operations, regulatory affairs, and medical affairs, achieving this iterative alignment is essential, especially in the context of…

Read More “Aligning Global Messaging Across Languages While Respecting Local Nuance” »

Common Translation Pitfalls That Trigger Ethics or Regulatory Findings In the realm of clinical trials, particularly in oncology clinical research, the importance of accurate and culturally sensitive translations cannot be overstated. As clinical operations, regulatory affairs, and medical affairs professionals navigate the maze of compliance and ethical challenges, understanding the potential pitfalls in translation processes…

Read More “Common Translation Pitfalls That Trigger Ethics or Regulatory Findings” »